Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...

But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s destructive genes and repurpose it as a “lentiviral vector”—a tool to deliver ...

It seemed like a very promising cancer immunotherapy lead. CHO Pharma, in Taiwan, had discovered that it was possible to target solid tumours with an antibody against a cell-surface glycolipid called ...

Detailed price information for Oxford Biomedica Plc (OXBDF) from The Globe and Mail including charting and trades.

SCD gene therapy approaches using CRISPR, gene therapy, and base editing show different stem cell outcomes in a mouse study.

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...